Abstract
YKL-40, a 40 kDa plasma protein, is secreted by macrophages, neutrophils, chondrocytes, vascular smooth muscle cells and cancer cells. High plasma YKL-40 is found in patients with inflammatory diseases and cancer, but it is not known how the protein is expressed in tissues. This immunohistochemical study was carried out with the purpose of mapping and grading cytoplasmic expression of YKL-40 in normal human tissue. Bovine serum albumin had to be used for pre-incubation in order to eliminate background staining of YKL-40. The majority of cells were stained, but the intensity varied, not just among different cell types but also within the same cell type. Cells known for exerting a high metabolic activity, i.e., high producing cells or cells with high turn-over, tended to show the most intense cytoplasmic staining, which was weak or lacking in cells with no or little activity. Many of these positive cells probably contribute to the YKL-40 found in plasma in healthy subjects in accordance with previous findings on their in vitro production of the protein. In conclusion, all cells with a functioning nucleus appeared to be capable of expressing YKL-40 in their cytoplasm, the intensity of which was dependent on cellular activity.
Similar content being viewed by others
References
Baeten D, Boots AM, Steenbakkers PG, Elewaut D, Bos E, Verheijden GF, Berheijden G et al (2000) Human cartilage gp-39+, CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum 43:1233–1243
Bernardi D, Podswiadek M, Zaninotto M, Punzi L, Plebani M (2003) YKL-40 is a marker of joint involvement in inflammatory bowel disease. Clin Chem 49:1685–1688
Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, Aerts JM, de Vries CJ (1999) Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 19:687–694
Dasuri K, Antonovici M, Chen K, Wong K, Standing K, Ens W, El-Gabalawy H et al (2004) The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res Ther 6:R161–R168
De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P (2001) YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 285:926–931
Fukushima N, Koopmann J, Sato N, Prasad N, Carvalho R, Leach SD, Hruban RH et al (2005) Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma. Modern Pathol 18:779–787
Fusetti F, Pijning T, Kalk KH, Bos E, Dijkstra BW (2003) Crystal structure and carbohydrate binding properties of the human cartilage glycoprotein-39. J Biol Chem 278:37753–37760
Hakala BE, White C, Recklies AD (1993) Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 268:25803–25810
Hashimoto S, Suzuki T, Dong HY, Yamazaki N, Matsushima K (1999) Serial analysis of gene expression in human monocytes and macrophages. Blood 94:837–844
Harvey S, Weisman M, O’Dell J, Scott T, Krusemeier M, Visor J, Swindlehurst C (1998) Chondrex: new marker of joint disease. Clin Chem 44:509–516
Houston DR, Recklies AD, Krupa JC, van Aalten DMF (2003) Structure and ligand induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes. J Biol Chem 278:30206–30212
Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V et al (2001) Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 98:15044–15049
Johansen JS, Williamson MK, Rice JS, Price PA (1992) Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 7:501–512
Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA (1996) Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 35:553–559
Johansen JS, Baslund B, Garbarsch C, Hansen M, Stoltenberg M, Lorenzen I, Price PA (1999) YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Arthritis Rheum 42:2624–2630
Johansen JS, Christoffersen P, Møller S, Price PA, Henriksen JH, Garbarsch C, Bendtsen F (2000) Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol 32:911–920
Johansen JS, Olee T, Price PA, Hashimoto S, Ochs RL, Lotz M (2001) Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum 44:826–837
Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N (2005) Increased serum YKL-40 in patients with pulmonary sarcoidosis. A potential marker of disease activity? Resp Med 99:396–402
Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA (2006) Review. Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev 15:194–202
Junker N, Johansen JS, Andersen CB, Kristjansen PEG (2005a) Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer 48:223–231
Junker N, Johansen JS, Hansen LT, Lund EL, Kristjansen PEG (2005b) Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Sci 96:183–190
Kamal SM, Turner B, He Q, Rasenack J, Bianchi L, Al Tawil A, Nooman A et al (2006) Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 43:771–779
Kawasaki M, Hasegawa Y, Kondo S, Iwata H (2001) Concentration and localization of YKL-40 in hip joint diseases. J Rheumatol 28:341–345
Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M (1997) Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 237:46–54
Koutroubakis IE, Petinaki E, Dimoulios P, Vardas E, Roussomoustakaki M, Maniatis AN, Kouroumalis EA (2003) Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Int J Colorectal Dis 18:254–259
Kronborg G, Østergaard C, Weis N, Nielsen H, Obel N, Pedersen SS, Price PA et al (2002) Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated to the outcome of the disease. Scand J Infect Dis 34:323–326
Lal A, Lash AE, Altschul SF, Velculescu V, Zhang L, McLendon RE, Marra MA et al (1999) A public database for gene expression in human cancers. Cancer Res 59:5403–5407
Ling H, Recklies AD (2004) The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular response to the inflammatory cytokines interleukin-1 and tumour necrosis factor-α. Biochem J 380:651–659
Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJ (1999) Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 250:168–173
Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, Hong RL, Lee K et al (2001) Differential gene expression profiling in human brain tumors. Physiol Genomics 5:21–33
Matsumoto T, Tsuromoto T (2001) Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laboratory parameters. Clin Exp Rheumatol 19:655–660
Morrison BW, Leder P (1994) neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 9:3417–3426
Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C, Ozburn N et al (2005) Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 65:1678–1686
Nishikawa KC, Millis AJT (2003) gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res 287:79–87
Nordenbaek C, Johansen JS, Junker P, Borregaard N, Sorensen O, Price PA (1999) YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis 180:1722–1726
Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimow AO (2005) YKL-40 is a different diagnostic marker for histologic subtypes of high-grade gliomas. Clin Cancer Res 11:2258–2264
Nyirkos P, Golds EE (1990) Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J 268:265–268
Nøjgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U, the EMALD Group (2003) Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol 39:179–186
Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, Colman H et al (2005) YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res 11:3326–3334
Peltomaa R, Paimela L, Harvey S, Helve T, Leirisalo-Repo M (2001) Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity. Rheumatol Int 20:192–196
Recklies AD, White C, Ling H (2002) The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J 365:119–126
Rehli M, Krause SW, Andresen R (1997) Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43:221–225
Rehli M, Niller HH, Ammon C, Langemann S, Schwarzfischer L, Andreesen R, Krause SW (2003) Transcriptional regulation of (CHI3L1), a marker gene for late stages of macrophage differentiation. J Biol Chem 278:44058–44067
Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, Hrebicek M et al (1998) Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 251:504–509
Shackelton LM, Mann DM, Millis AJT (1995) Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodelling. J Biol Chem 270:13076–13083
Sjögren H, Meis-Kindblom JM, Ôrndal C, Bergh P, Ptaszynski K, Åman P, Kindblom LG et al (2003) Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses. Am J Pathol 162:781–792
Suzuki T, Hashimoto S, Toyoda N, Nagai S, Yamazaki N, Dong H-Y, Sakai J et al (2000) Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 96:2584–2591
Tanwar MK, Gilbert MR, Holland EC (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62:4364–4368
Tran A, Benzaken S, Saint-Paul MC, Guzman-Granier E, Hastier P, Pradier C, Barjoan EM et al (2000) Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 12:989–993
Verhoeckx KCM, Bijlsma S, de Groene EM, Witkamp RF, van der Greef J, Rodenburg RJT (2004) A comparison of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics 4:1014–1028
Vind I, Johansen JS, Price PA, Munkholm P (2003) Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 38:599–605
Volck B, Price PA, Johansen JS, Sørensen O, Benfield TL, Nielsen HJ, Calafat J et al (1998) YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 4:351–360
Volck B, Østergaard K, Johansen JS, Garbarsch C, Price PA (1999) The distribution of YKL-40 in osteoartrhitic and normal human articular cartilage. Scand J Reumatol 28:171–179
Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Østergaard M, Ostergaard K et al (2001) Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 9:203–214
Acknowledgements
We want to thank technologist Hanife Dzaferi, Drs. Anne Roslind and Eva Balslev, Herlev Hospital, University of Copenhagen and technologist Heidi Marie Paulsen, Rigshospitalet, University of Copenhagen, for technical support. We also want to thank Drs. Helle Broholm and Søren Daugaard, Rigshospitalet, University of Copenhagen, and Dr. Bente Pakkenberg, Bispebjerg Hospital, University of Copenhagen for supply of tissue sections from brain, cartilage and bone.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s10735-007-9100-y
Rights and permissions
About this article
Cite this article
Ringsholt, M., Høgdall, E.V.S., Johansen, J.S. et al. YKL-40 protein expression in normal adult human tissues – an immunohistochemical study. J Mol Hist 38, 33–43 (2007). https://doi.org/10.1007/s10735-006-9075-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-006-9075-0